Articles

Artificial Intelligence, Learning and Explosive Growth in Cannabis

Publish Date: March 13, 2019

Author: Rob Ayre, Communications Manager, Docebo Canada Inc.

Organizations operating in the industry have a distinct need for clear communication across multiple departments and sophisticated ways of training new employees quickly to ensure compliance, efficiency and more. Companies looking to grow and capitalize need to be agile and have the ability to train employees on the latest information necessary for success.

Read The Full Story

With high growth, comes high risk: Is the cannabis industry data protection ready?

Publish Date: November 12, 2018

Author: Paul Saabas, Vice President, Shred-it

Many LPs operate clinics and dispensaries that collect personal and confidential medical information from patients. Cannabis players that chose to operate in the recreational space still collect personal information from customers and need to ensure that they hold themselves to the same standards as hospitals and medical clinics when it comes to information protection. A 2017 report from the Ponemon Institute states that healthcare organizations that had a data breach experienced a 6.25% decline in their stocks, lost more than 4% of patients and it took over three months to recover from the financial damages of the breach. It is expected that this same decline in stocks and customers can be seen in both the recreational and medicinal cannabis markets if a breach occurs.

Read The Full Story

Lessons from the U.S.: With Legalization Here Origin House Eyes Opportunities in Canadian Cannabis

Publish Date: October 31, 2018

Author: Afzal Hasan

An interview with Afzal Hasan is the President and General Counsel of Origin House.

Read The Full Story

How to Sell Cannabis in a Regulated Retail Environment (Automated Dispensing Systems)

Publish Date: October 10, 2018

Author: Markus Merrill - General Manager (Canada) - Vend Data Media Solutions

Vend Data Media Solutions (VDMS), as its name suggests, provides automated product dispensing for retailers and is a digital media platform for in-store advertising. The term “vending” leads people to believe that we are providing a customer-facing, interactive kiosk, which is not the case. Our systems are installed behind the counter, in back offices or storage areas to help protect, control and automate the sale of high-regulated products.

Read The Full Story

Canada’s Next Biggest Natural Health Product: CBD?

Publish Date: August 29, 2018

Author: Michael Ciardullo - Cannabis Licensing Lead - Regulatory Affairs/Quality Assurance Associate and Leteasha Gorham – Cannabis Market Innovation Lead – Senior Regulatory Affairs Specialist

There are a number of special compounds, including CBD, that the plant produces that are unique to the plant genus Cannabis. These compounds are known collectively as Phytocanabinoids, and include what was hoped to become Canada’s next biggest natural health product: CBD.

Read The Full Story

New Tobacco and Vaping Products Legislation under the CCPSA

Publish Date: August 29, 2018

Author: Monica Banach

In May of this year, the Bill S-5 received Royal Assent for Canada’s new Tobacco and Vaping Products Legislation (TVPA). With this update, all vaping products that are not subject to the Food and Drug Act (i.e. marketed without therapeutic claims) are subject to all of the requirements of the Canada Consumer Product Safety Act (CCPSA) and its applicable regulations, including the Consumer Chemicals and Containers Regulations, 2001 (CCCR 2001), which incorporate toxicity provisions.

Read The Full Story

Three Things to Know About Ontario’s Retail Cannabis Market

Publish Date: August 26, 2018

Author: Rahul Sethi

As legalization continues to roll out in Ontario, here are another three key things to know.

Read The Full Story

Addressing Rising Expectations for Accurate Labeling and Dosing

Publish Date: August 26, 2018

Author: Guy Setton, Ph.D.

Accurate drug labeling is critically important for patient and consumer health, and medical cannabis is no exception. It is only a matter of time before cannabis products will be subject to the same regulatory scrutiny as other prescription drugs and dietary supplements.  

Read The Full Story